The recent ruling by the Delhi High Court regarding Biotyx Medical (Shenzhen) Co. Ltd.’s patent application has significant ...
(Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases ...
Cambridge company coding human cells for novel cures and a pioneer in synthetic biology, has successful defended its ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics, a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development ...
bit.bio, the company coding human cells for novel cures and a pioneer in synthetic biology, today announces the successful defence of its foundational European patent for opti-ox, a breakthrough ...
The Central Intellectual Property and International Trade Court has confirmed that a design’s overall appearance should be ...
Defensive protection is the best choice for protecting cultural and traditional products from being exploited by third parties ...
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...